As of January 2025, Bliss GVS Pharma has a market cap of $196.58M. This makes Bliss GVS Pharma the world's 16492th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $144.92M | -5.42% |
2023 | $153.22M | 72.17% |
2022 | $89.00M | -30.18% |
2021 | $127.47M | -48.70% |
2020 | $248.49M | 34.14% |
2019 | $185.24M | -8.67% |
2018 | $202.82M | -22.17% |
2017 | $260.59M | 36.12% |
2016 | $191.45M | -11.53% |
2015 | $216.40M | 177.46% |
2014 | $77.99M | 52.89% |
2013 | $51.01M | -2.47% |
2012 | $52.30M | 100.71% |
2011 | $26.06M | -38.55% |
2010 | $42.41M | - |